1/3
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai |
|---|
No analytics yet
Send a link to your students to track their progress
BZDs
MOA: Enhance inhibitory effects of GABA by binding to allosteric site on GABA-A = increase affinity of GABA binding = increase frequency of chloride channel opening
Short acting (1-15 hr)
Triazolam
Midazolam
Immediate-acting (15-20 hr) “A LOT”
Alprazolam (Xanax)
Oxazepam
Lorazepam (Ativan)
Temazepam (Restoril)
Long-acting (>20 hrs) 3CDF
Chlordiazepoxide
Clonazepam (Klonopin)
Diazepam (Valium)
Flurazepam
Clorazepate (Tranxene-T)
BZD Antidote
Flumazenil (Romazicon)
MOA: competitive GABA receptor antagonist
Non-BZD
Buspirone (Buspar)
MOA: may be due to affinity for 5-HT1A and 5-HT2 receptors
Propranolol
MOA: competitive non-selective beta-1 and beta-2 adrenergic receptor blocker
Beta blocker
Propranolol
MOA: competitive non-selective beta-1 and beta-2 adrenergic receptor blocker
physical symptoms only